new glp 1 drugs 2025 project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these at scale. Our GLP-1 Diabetes Weight Loss Drugs

In addition, some covariates such as smoking and alcohol consumption were crudely estimated through diagnosis codes and previous medications

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm2016: executive summary

Management of hyperglycemia in type 2 diabetes, 2022

For instance, it partnered with a health app to help patients manage lifestyle changes alongside drug therapy a move to augment the effectiveness of its new drug treatments

[174] An observational study on people with obesity and type 2 diabetes and heart failure with preserved ejection fraction, semaglutide had about a 42% lower risk of hospitalization for heart failure and all-cause death combined compared with sitagliptin